@article{Burmester_2014,<br/><span class="tab"></span> title={Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study},<br/><span class="tab"></span> volume={16},<br/><span class="tab"></span> ISSN={1478-6354},<br/><span class="tab"></span> url={http://dx.doi.org/10.1186/ar4452},<br/><span class="tab"></span> DOI={10.1186/ar4452},<br/><span class="tab"></span> number={1},<br/><span class="tab"></span> journal={Arthritis Research &amp; Therapy},<br/><span class="tab"></span> publisher={Springer Science and Business Media LLC},<br/><span class="tab"></span> author={Burmester,<br/><span class="tab"></span> Gerd R and Matucci-Cerinic,<br/><span class="tab"></span> Marco and Mariette,<br/><span class="tab"></span> Xavier and Navarro-Blasco,<br/><span class="tab"></span> Francisco and Kary,<br/><span class="tab"></span> Sonja and Unnebrink,<br/><span class="tab"></span> Kristina and Kupper,<br/><span class="tab"></span> Hartmut},<br/><span class="tab"></span> year={2014},<br/><span class="tab"></span> pages={R24} }